US hip and knee replacement market is expected to witness robust growth in 20082015
The US Hip and Knee Replacement Market Set To Boom in The Next Seven Years Driven By Aging Population In 2008 the US hip and knee replacement market was valued at $6.7 billion and is forecast to grow by 11.9% over the next seven years to reach $14.8 billion. The US knee replacement market was valued at $4.1 billion in 2008 and is projected to grow at 12.9% for the next seven years to reach $9.6 billion by 2015.The knee replacement market was the largest segment with 59% contribution to the total joint replacement market while the hip replacement market contributed 38% in 2008. The market is expected to be driven through 20082015 by; increasing incidence of osteoarthritis aging demographics trend towards early surgical intervention in younger patients emergence of new procedures such as joint resurfacing and greater penetration of existing technologies.
Hip and knee joint replacement market to be driven by joint replacements in adults below 65 years The hip and knee replacement markets are both expected to be primarily driven by the younger 4565 year demographic going for early joint replacement in the future. Companies are increasingly targeting these individuals through advanced joint implants new minimal invasive procedures and direct to customer marketing. Improved implant materials and innovative design are increasing the life of the implants enabling younger patients to undergo treatment without worrying about implant failure later in life. Advancements in procedures have led to the emergence of minimal invasive techniques and partial joint replacements which enable early recovery and greater range of movement. These incremental technological breakthroughs are enabling younger patients to safely undergo joint replacements. Direct to customer marketing is also helping create a positive perception about the surgery promoting it as a lifestyle option in which individuals can remain more active into old age.
Incremental technology innovation will drive the market Product innovations in the fields of implant material and design which improve implant durability is going to drive increased patient volumes especially among the younger population. Implant materials such as advanced titanium alloys have lead to a resurgence of metal-on-metal implants while cross-linked polyethylene has enhanced the durability of metal-on-polymer implants. Newer designs which provide more choice of sizes and allow for larger femoral heads have also improved surgery outcomes by providing better stability reduced chances of dislocation post operation and reduced wear and tear due to better fit. The emergence of custom-fit implants especially knee implants which are the largest load bearing joints in the body is also expected to drive the market. Almost all the leading players have customized implants and instrumentation in the market. All these incremental innovations have vastly improved surgery outcomes and made surgery intervention more appealing to those who earlier waited a few years before undergoing replacement. This expansion of the patient population is expected to drive the market. Overall the US hip and knee replacement market is expected to witness robust growth in 20082015 as a result of the increased number of younger patients going for surgery and increased market penetration of existing technologies.
Zimmer DePuy and Stryker dominate the US hip and knee market Zimmer Holdings Inc Stryker Corp. and DePuy Inc. are the leading competitors in the US hip and knee replacement market together accounting for 70% of market share in 2008. Other significant players are Smith & Nephew and Biomet. Zimmer is the market leader in both hip and knee replacement markets with a 29% and 26% market share respectively. Product differentiation; especially in the knee replacement market such as gender solutions and a range of high-flex knees; has enabled Zimmer to maintain its dominance. Zimmer recently announced that it will start developing products aimed at meeting the specific needs of obese patients. However in 2008 it lost some market share in the hip replacement market due to product recall of Durom Acetabular component following reports of cup loosening and high revision rates.
To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=129852&rt=US-Hip-and-Knee-Implants-Strategic-Market-Analysis-and-Insight-to-2015.html
You May Also Like